english.prescrire.org > Topics > Advancing healthcare policy > Advancing healthcare policy in Europe: a chronological recap of actions > 2021 Recap > Prescrire's response to the public consultation on the revision of European pharmaceuticals legislation (12/2021)

Advancing healthcare policy

Advancing healthcare policy in Europe: a chronological recap of actions

A recap of actions in 2021
Prescrire's response to the public consultation on the revision of European pharmaceuticals legislation (December 2021)


Paris, 15 December 2021


In its response, Prescrire stressed the need for robust evidence before marketing authorisation is granted. Accelerated assessments should be limited to real unmet health needs, with due attention paid to whether post-marketing commitments are fulfilled. To ensure safety of supply, there is a need for diversification of supply chains and transparency over production sites and capacity.

> Click here to download Prescrire's contribution (pdf, 145 Ko)


©Prescrire December 2021
 

Share Share on Facebook Share on Twitter